Skip to main content
. 2019 Jul 14;23(9):5907–5919. doi: 10.1111/jcmm.14386

Figure 3.

Figure 3

(A,B) Cell migration assay showed that silence of NR2F1‐AS1 could greatly inhibit cell migration in FTC‐133 cells and B‐CPAP cells compared with negative control (NC) group; (C,D) Flow cytometry assay showed that silence of NR2F1‐AS1 could greatly increase cell apoptosis in both FTC‐133 cells and B‐CPAP cells compared with NC group. **P < 0.01